TOMI Environmental Solutions installed a $500,000 disinfection system in a UK pharmaceutical facility, enhancing decontamination capabilities.
Quiver AI Summary
TOMI Environmental Solutions, Inc. announced the installation of a Custom Engineered Solution (CES) at a pharmaceutical facility in the UK, reflecting a $500,000 investment aimed at enhancing decontamination capabilities. This new twelve-applicator CES system utilizes TOMI's SteraMist iHP technology, allowing for efficient decontamination without the need for full facility shutdowns, thus maintaining operations. CEO Dr. Halden Shane highlighted the growing demand for their technology among life science leaders and expressed enthusiasm for showcasing their upgraded systems and expertise. This development aligns with TOMI's strategy to strengthen its global presence through innovative disinfection technologies.
Potential Positives
- TOMI Environmental Solutions has secured a significant $500,000 investment for a new twelve-applicator Custom Engineered Solution (CES) in a pharmaceutical facility, indicating strong market demand for its products.
- The installation enhances the decontamination capabilities of the facility without the need for full shutdowns, demonstrating TOMI's ability to support continuous operations for critical industries.
- This milestone reflects TOMI's strategy to expand its presence in key markets, highlighting its innovative technology and customized solutions tailored to industry needs.
- Dr. Halden Shane, CEO, emphasizes the growing demand for SteraMist technology among life science industry leaders, reinforcing TOMI's position as a trusted provider in this field.
Potential Negatives
- The press release emphasizes reliance on a single product line, which raises concerns about revenue diversification and long-term sustainability.
- It includes a cautionary note about forward-looking statements, highlighting potential risks and uncertainties that may affect actual performance compared to management’s expectations.
- The heavy reliance on the growth of a single technology (SteraMist) could indicate vulnerabilities in market performance if demand shifts or competition increases.
FAQ
What is TOMI Environmental Solutions, Inc.?
TOMI Environmental Solutions, Inc. is a global company specializing in disinfection and decontamination solutions, particularly with its SteraMist technology.
What recent investment has TOMI made in the UK?
TOMI announced a $500,000 investment in a new twelve-applicator Custom Engineered Solution system at a pharmaceutical facility in the UK.
How does SteraMist technology work?
SteraMist technology uses patented ionized Hydrogen Peroxide (iHP) to provide efficient and rapid disinfection without requiring full facility shutdowns.
What industries does TOMI serve?
TOMI serves a variety of industries, including healthcare, pharmaceutical, education, food processing, and first responders, utilizing its advanced decontamination technologies.
Where can I learn more about TOMI's products?
For more information on TOMI's products, visit their website at http://www.steramist.com or contact them at info@tomimist.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOMZ Hedge Fund Activity
We have seen 6 institutional investors add shares of $TOMZ stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SCARBOROUGH ADVISORS, LLC added 79,413 shares (+inf%) to their portfolio in Q3 2024
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 63,933 shares (-100.0%) from their portfolio in Q2 2024
- DYNAMIC ADVISOR SOLUTIONS LLC added 30,000 shares (+150.0%) to their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 17,374 shares (-100.0%) from their portfolio in Q3 2024
- COMMONWEALTH EQUITY SERVICES, LLC added 11,050 shares (+inf%) to their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC removed 10,100 shares (-100.0%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 10,083 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
FREDERICK, Md., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announced today another installation of the Custom Engineered Solution (CES) at a renowned pharmaceutical facility in the United Kingdom.
This pharmaceutical facility is expanding its decontamination capabilities with a $500,000 investment in a new twelve-applicator CES system. By leveraging TOMI’s highly effective SteraMist iHP technology, the company ensures efficient and rapid decontamination without full facility shutdowns, eliminating interruptions and maintaining continuous operations. This milestone underscores TOMI’s strategy to expand its presence in critical markets through superior technology and innovative, customized equipment offerings worldwide.
Dr. Halden Shane, CEO of TOMI Environmental Solutions, commented, “This installation demonstrates the increased demand for our SteraMist technology by life science industry leaders. We look forward to showcasing our latest upgraded CES system, robust technical team, and streamlined operations during the design and installation of this international custom system.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:
TOMZ
) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit
http://www.steramist.com
or contact us at
info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve education sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
